Bold Capital Partners logo

Bold Capital Partners

North America, California, United States, Santa Monica

Description

Bold Capital Partners, based in Santa Monica, California, is a venture capital firm co-founded by XPRIZE founder Peter Diamandis and entrepreneur Robert Herjavec. The firm specializes in early-stage investments, primarily targeting Series A and Series B rounds, with a strategic focus on "exponential technologies" and "frontier tech." They aim to back companies that are leveraging disruptive innovations to transform industries.

Their investment thesis centers on companies utilizing advancements in areas such as artificial intelligence, robotics, biotechnology, space exploration, and advanced materials. Bold Capital seeks out ventures with the potential to create significant market shifts, achieve "10x improvements," or address "billion-dollar markets." The firm has successfully raised multiple funds, with their latest, Fund III, closing at a substantial $250 million. This capital base enables them to make meaningful initial investments and provide ongoing support to their portfolio companies through subsequent funding rounds.

While specific check sizes can vary depending on the opportunity and stage, Bold Capital typically deploys initial investments ranging from approximately $3 million to $15 million, often co-investing alongside other prominent venture firms. Their value proposition extends beyond capital, offering portfolio companies access to a robust network of strategic partners, industry experts, and the unique insights of their founders, particularly in areas related to innovation and exponential growth. Bold Capital Partners positions itself as a long-term partner for visionary entrepreneurs building the next generation of transformative companies.

Investor Profile

Bold Capital Partners has backed more than 106 startups, with 8 new investments in the last 12 months alone. The firm has led 23 rounds, about 22% of its total and boasts 5 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series B, Seed rounds (top funding stages).
  • Majority of deals are located in United States, Hong Kong, Canada.
  • Strong thematic focus on Health Care, Biotechnology, Artificial Intelligence (AI).
  • Led 4 rounds in the past year.
  • Typical check size: $3M – $15M.

Stage Focus

  • Series A (35%)
  • Series B (23%)
  • Seed (20%)
  • Series Unknown (10%)
  • Series C (5%)
  • Series D (3%)
  • Pre Seed (2%)
  • Convertible Note (1%)
  • Series F (1%)
  • Series E (1%)

Country Focus

  • United States (91%)
  • Hong Kong (6%)
  • Canada (2%)
  • Finland (1%)
  • Israel (1%)

Industry Focus

  • Health Care
  • Biotechnology
  • Artificial Intelligence (Ai)
  • Software
  • Medical
  • Medical Device
  • Therapeutics
  • Machine Learning
  • Robotics
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Bold Capital Partners frequently co-invest with?

Gaingels
North America, Vermont, United States, Burlington
Co-Investments: 6
Plum Alley
North America, New York, United States, New York
Co-Investments: 4
Draper Associates
North America, California, United States, San Mateo
Co-Investments: 4
WestRiver Group
North America, Washington, United States, Kirkland
Co-Investments: 5
S2G Ventures
North America, Illinois, United States, Chicago
Co-Investments: 5
Breyer Capital
North America, California, United States, Menlo Park
Co-Investments: 4
DCVC
North America, California, United States, San Francisco
Co-Investments: 5
Intel Capital
North America, California, United States, Santa Clara
Co-Investments: 4
Pavilion Capital
North America, New York, United States, New York
Co-Investments: 5
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 19

Which angels does Bold Capital Partners often collaborate with?

EM
Europe, England, United Kingdom, London
Shared Deals: 1
AZ
Europe, England, United Kingdom, London
Shared Deals: 2
BN
North America, Illinois, United States, Chicago
Shared Deals: 1
MB
North America, California, United States, San Francisco
Shared Deals: 2
ED
North America, New York, United States, New York
Shared Deals: 2
RN
North America, New York, United States, New York
Shared Deals: 4
TT
North America, Pennsylvania, United States, Pittsburgh
Shared Deals: 2
AW
North America, California, United States, San Francisco
Shared Deals: 2
PG
Europe, England, United Kingdom, London
Shared Deals: 2
SS
North America, California, United States, Los Angeles
Shared Deals: 2

What are some of recent deals done by Bold Capital Partners?

Aqtual

Hayward, California, United States

Aqtual is a biotechnology diagnostics platform that provides healthcare solutions, novel technology, and biochemistry for chronic disease.

BiotechnologyHealth CareMachine LearningWellness
Series BJul 10, 2025
Amount Raised: $31,000,000
Centivax

South San Francisco, California, United States

Centivax is a biotechnology company that develops vaccines and therapeutic antibodies targeting infectious diseases and venomous threats.

BiotechnologyHealth CareHealth DiagnosticsMedicalTherapeutics
Series AJul 8, 2025
Amount Raised: $45,000,000
Syntis Bio

Boston, Massachusetts, United States

Syntis Bio operates as a late-stage preclinical company that develops oral therapies for obesity, diabetes, and rare diseases.

Health CareMedicalTherapeutics
Series AJul 1, 2025
Amount Raised: $33,000,000
Gallant Therapeutics

San Diego, California, United States

Gallant Therapeutics is an animal health biotechnology company.

Biotechnology
Series BJun 30, 2025
Amount Raised: $18,000,000
Near Space Labs

Brooklyn, New York, United States

Near Space Labs provides aerial imagery using zero-emission balloons to support mapping, urban planning, and environmental monitoring.

AerospaceComputer VisionGeospatialRoboticsSoftware
Series BApr 29, 2025
Amount Raised: $20,000,000
Chef Robotics

San Francisco, California, United States

Chef Robotics is a robotics and artificial intelligence company serving the food industry.

Artificial Intelligence (AI)Food and BeverageMachine LearningRobotics
Series AMar 31, 2025
Amount Raised: $20,600,000
Esperto Medical

Orange, California, United States

Esperto's patented technology uses sound waves to measure blood pressure without an inflating cuff

Health DiagnosticsMedical Device
Series AOct 24, 2024
Feno

Culver City, California, United States

Feno provides oral health insights that could signal systemic issues.

Artificial Intelligence (AI)Consumer ElectronicsHealth CarePersonal Health
SeedSep 25, 2024
Amount Raised: $6,000,000
Discure Technologies

Herzliya, Tel Aviv, Israel

Discure Technologies is developing a minimally invasive, implantable bioelectronic device.

Medical Device
Series ASep 10, 2024
Amount Raised: $11,000,000
Viome

Bellevue, Washington, United States

Viome is a provider of comprehensive health insights designed to help people track their gut microbiome health.

Dietary SupplementsHealth CareMedicalWellness
Series DSep 10, 2024
Amount Raised: $25,000,000